AMD eyes new highs as Q2 earnings near, fueled by surging AI chip demand, data center growth, and China tailwinds.

CVS, JNJ, and Tenet Healthcare shine as defensive picks with strong earnings momentum and attractive valuations.

The results topped Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of $2.30 per share. The natural gas company posted revenue of ...

MIAMI (AP) — MIAMI (AP) — WhiteHorse Finance Inc. (WHF) on Thursday reported second-quarter profit of $2.3 million. On a per-share basis, the Miami-based company said it had net income of 10 cents.

TROY, Mich. (AP) — TROY, Mich. (AP) — Kelly Services Inc. (KELYA) on Thursday reported second-quarter earnings of $19 million. On a per-share basis, the Troy, Michigan-based company said it had profit ...

THE WOODLANDS, Texas (AP) — THE WOODLANDS, Texas (AP) — Target Hospitality Corp. (TH) on Thursday reported a loss of $14.9 million in its second quarter. On a per-share basis, the The Woodlands, Texas ...

BOSTON (AP) — BOSTON (AP) — Ironwood Pharmaceuticals Inc. (IRWD) on Thursday reported second-quarter profit of $23.6 million. On a per-share basis, the Boston-based company said it had net income of ...

Monte Rosa Therapeutics Inc. (GLUE) on Thursday reported a loss of $12.3 million in its second quarter. On a per-share basis, the Boston-based company said it had a loss ...

(RGNX) on Thursday reported a loss of $70.9 million in its second quarter. On a per-share basis, the Rockville, Maryland-based company ...

CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Cullinan Therapeutics, Inc. (CGEM) on Thursday reported a loss of $70.1 million in its second quarter. The Cambridge, Massachusetts-based company said ...

SUMMIT, N.J. (AP) — SUMMIT, N.J. (AP) — Kenvue Inc. (KVUE) on Thursday reported second-quarter earnings of $420 million. The Summit, New Jersey-based company said it had profit of 22 cents per share.

The results surpassed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 16 cents per share.